InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Drugs battles prove a headache for patent owners

Shahnaz Mahmud, New York and James Nurton, London

The world's two biggest-selling drugs are at the centre of patent disputes that demonstrate the increasingly aggressive stance generic companies are taking against blockbuster drugs coming towards the end of their patent life.

Drugs company Pfizer stands to lose more...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null null

null null null

November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing

Most read articles